In the realm of supply chain, data visibility through technology is a game changer, helping to eliminate the stock-outs and expiries that are still endemic at service delivery points. However, Chris Wright reminds us, technology is useless without people who are skilled at interpreting and applying the data technology yields.
A recent report from the Centers for Disease Control and Prevention that most boys aren’t receiving the HPV vaccine is not surprising, but there is some exciting news lurking in the study’s finding: The boys who are more likely to receive the HPV vaccine are the traditionally underserved – those who are minority, Hispanic, lower income, or in a single-mother household.
With support from the USAID | DELIVER PROJECT, Tanzania has improved efficiency and reduced costs associated with its health supply chain by introducing a logistics management unit and electronic logistics information management system (eLMIS).
A new study in The Lancet shows promising gains in disability-adjusted life years and healthy life expectancy worldwide. JSI’s Chris Wright anticipates how these changes will impact global public health supply chains.
Extensive technical support, resources, and continuous monitoring are required to introduce new and underutilized vaccines. In this blog post, JSI’s Michel Othepa lays out process of new vaccine introduction.
Vaccine supply chains require dedicated data management and reporting systems. In Tanzania, JSI is supporting the Ministry of Health and Social Welfare in the development and implementation of an electronic vaccine information system that is integrated with the overarching electronic logistics management information system (eLMIS) while addressing the unique needs of vaccine supply chain management.
JSI’s Motuma Admassu shares highlights from the 2015 Fleet Forum Conference.
JSI’s Chris Wright shares insights from the #TechNetConference and highlights a presentation on the USAID |DELIVER PROJECT’s work in Pakistan developing a vaccine logistics management information system (vLMIS).
HPV affects millions and millions of people. HPV is the most common sexually transmitted infection, and an estimated 20 million people have the active virus at any time, according to WHO. While in the U.S., the HPV vaccine was licensed for girls in 2006, and for boys in 2009, in many other countries, the vaccine is only just being rolled out now. JSI’s Allison Hackbarth and Vanessa Richart describes efforts being made internationally in and in the U.S. to expand access to HPV vaccine.
April 24-30 is World Immunization Week. Mike Favin and Rebecca Fields of the Maternal and Child Survival Program (MCSP) explain how the project is promoting community participation to increase immunization rates using the “My Village, My Home” tool.